Mwt. LogP HBD HBA PSA RB CSP3
96.0 -2.2 1 3 83.0 0 0.0
UNII
4J9FJ0HL51
CAS
7778-77-0
SYNONYMS
  • Potassium Dihydrogen Orthophosphate
  • Potassium Acid Phosphate
  • Monobasic Potassium Phosphate
  • Monopotassium Dihydrogen Phosphate
  • Monopotassium Orthophosphate
  • Monopotassium Phosphate
  • Potassium Dihydrogen Phosphate
  • Potassium Dihydrogen Phosphate [ep]
  • Monobasic Potassium Phosphate [mart.]
  • Monobasic Potassium Phosphate [usp-Rs]
  • Potassium Phosphate [inci]
  • Potassium Phosphate Monobasic
  • Potassium Phosphate Monobasic [who-Dd]
  • E-340(i)
  • Ins-340(i)
  • Ins No.340(i)
  • Monopotassium Dihydrogen Monophosphate
  • Monopotassium Dihydrogen Orthophosphate
  • Monopotassium Monophosphate
  • Potassium Biphosphate
ZINC ID(s)
Availability
Present in 0 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Dosages

Route Formulation Per Unit Dose
An,infiltration Injection 2.72%
Auricular (otic) Solution 0.2%
Im - Iv Injection 0.1%
Intra-Articular Injection 0.3%
Intramuscular Injectable 0.1%
Intramuscular Injection 0.3%
Intrauterine Solution
Intravenous Injectable 0.1%
Intravenous Injection 6.8%
Intravenous Solution, Injection 0.09%
Intravesical Solution, Injection 2.92%
Iv(infusion) Solution, Injection 1.36%
Nasal Solution 0.07%
Nasal Spray 0.14%
Nerve Block Injection 2.72%
Ophthalmic Solution 0.2%
Ophthalmic Suspension 0.44%
Subcutaneous Powder, For Injection Solution, Lyophilized 0.12%
Oral Emulsion
Oral Capsule, Enteric Coated Pellets 17MG
Oral Solution 0.4%
Oral Solution, Syrup 0.48%
Oral Suspension 1%
Oral Syrup 0.27%
Oral Tablet 25MG
Oral Tablet, Sustained Action 4MG

More Information

Usage Over Time

Comments